ID   XRN2_CAEEL              Reviewed;         975 AA.
AC   Q9U299;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   29-SEP-2021, entry version 143.
DE   RecName: Full=5'-3' exoribonuclease 2 homolog;
DE            EC=3.1.13.- {ECO:0000269|PubMed:19734881, ECO:0000269|PubMed:24462208, ECO:0000269|PubMed:26779609};
GN   Name=xrn-2 {ECO:0000312|WormBase:Y48B6A.3};
GN   ORFNames=Y48B6A.3 {ECO:0000312|WormBase:Y48B6A.3};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   FUNCTION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, INDUCTION, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=16122351; DOI=10.1371/journal.pbio.0030312;
RA   Frand A.R., Russel S., Ruvkun G.;
RT   "Functional genomic analysis of C. elegans molting.";
RL   PLoS Biol. 3:E312-E312(2005).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=19734881; DOI=10.1038/nature08349;
RA   Chatterjee S., Grosshans H.;
RT   "Active turnover modulates mature microRNA activity in Caenorhabditis
RT   elegans.";
RL   Nature 461:546-549(2009).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=21397849; DOI=10.1016/j.devcel.2011.02.008;
RA   Chatterjee S., Fasler M., Bussing I., Grosshans H.;
RT   "Target-mediated protection of endogenous microRNAs in C. elegans.";
RL   Dev. Cell 20:388-396(2011).
RN   [5]
RP   SUBCELLULAR LOCATION.
RX   PubMed=23541767; DOI=10.1016/j.molcel.2013.02.023;
RA   Bosse G.D., Ruegger S., Ow M.C., Vasquez-Rifo A., Rondeau E.L.,
RA   Ambros V.R., Grosshans H., Simard M.J.;
RT   "The decapping scavenger enzyme DCS-1 controls microRNA levels in
RT   Caenorhabditis elegans.";
RL   Mol. Cell 50:281-287(2013).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH PAXT-1, DEVELOPMENTAL STAGE,
RP   DISRUPTION PHENOTYPE, AND MUTAGENESIS OF 234-ASP--ASP-236.
RX   PubMed=24462208; DOI=10.1016/j.molcel.2014.01.001;
RA   Miki T.S., Richter H., Rueegger S., Grosshans H.;
RT   "PAXT-1 promotes XRN2 activity by stabilizing it through a conserved
RT   domain.";
RL   Mol. Cell 53:351-360(2014).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.84 ANGSTROMS) OF 1-787 IN COMPLEX WITH PAXT-1,
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=26779609; DOI=10.1038/nsmb.3155;
RA   Richter H., Katic I., Gut H., Grosshans H.;
RT   "Structural basis and function of XRN2 binding by XTB domains.";
RL   Nat. Struct. Mol. Biol. 23:164-171(2016).
CC   -!- FUNCTION: Possesses 5'->3' exoribonuclease activity (PubMed:19734881,
CC       PubMed:21397849). Plays a role in maintenance of steady-state
CC       concentration and turnover of microRNAs (miRNA) by degradation of
CC       mature miRNA (PubMed:19734881, PubMed:21397849, PubMed:26779609).
CC       Degradation role is enhanced when in complex with paxt-1
CC       (PubMed:24462208, PubMed:26779609). Partially redundant to xrn-1 in
CC       miRNA guide strand degradation (PubMed:19734881, PubMed:21397849).
CC       Implicated in differential regulation of mRNAs such as let-7 by
CC       controlling the accumulation of mature miRNA (PubMed:19734881,
CC       PubMed:21397849). Positively regulates molting of the pharyngeal
CC       cuticle (PubMed:16122351, PubMed:19734881).
CC       {ECO:0000269|PubMed:16122351, ECO:0000269|PubMed:19734881,
CC       ECO:0000269|PubMed:21397849, ECO:0000269|PubMed:24462208,
CC       ECO:0000269|PubMed:26779609}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.3913 uM for FAM fluorophore-coupled RNA substrate and a
CC         quencher-coupled DNA primer {ECO:0000269|PubMed:26779609};
CC         Vmax=0.000197 umol/sec/ug enzyme {ECO:0000269|PubMed:26779609};
CC   -!- SUBUNIT: Interacts with paxt-1 (via N-terminus); the interaction is
CC       direct and results in stabilization of xrn-2 in the complex.
CC       {ECO:0000269|PubMed:24462208, ECO:0000269|PubMed:26779609}.
CC   -!- INTERACTION:
CC       Q9U299; Q21738: paxt-1; NbExp=5; IntAct=EBI-320499, EBI-11705385;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:23541767}.
CC   -!- TISSUE SPECIFICITY: Expressed in the pharyngeal myoepithelium and
CC       intestine. Also expressed in several anterior neurons including the
CC       sensory neurons, as well as the interneuron PVT and the pharyngeal
CC       motorneuron M5. {ECO:0000269|PubMed:16122351}.
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout all developmental stages.
CC       Detected in the M5 pharyngeal neuron only in larvae. Also persistently
CC       expressed in the intestine of adults past the molting stage.
CC       {ECO:0000269|PubMed:16122351, ECO:0000269|PubMed:24462208}.
CC   -!- INDUCTION: Up-regulated prior to molting.
CC       {ECO:0000269|PubMed:16122351}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown results in impaired miRNA
CC       degradation leading to accumulation of mature miRNA passenger (miR*)
CC       strands (PubMed:19734881, PubMed:21397849). Defective molting owing to
CC       failure to shed cuticle from the pharynx in the late L4-stage larvae
CC       (PubMed:16122351). Suppresses the vulval bursting phenotype of let-7
CC       mutant (PubMed:19734881). Reduced paxt-1 expression (PubMed:24462208).
CC       {ECO:0000269|PubMed:16122351, ECO:0000269|PubMed:19734881,
CC       ECO:0000269|PubMed:21397849, ECO:0000269|PubMed:24462208}.
CC   -!- SIMILARITY: Belongs to the 5'-3' exonuclease family. XRN2/RAT1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL110490; CAB54449.2; -; Genomic_DNA.
DR   PIR; T27005; T27005.
DR   RefSeq; NP_496958.2; NM_064557.5.
DR   PDB; 5FIR; X-ray; 2.84 A; A/C/E/G/I/K=1-787.
DR   PDBsum; 5FIR; -.
DR   SMR; Q9U299; -.
DR   BioGRID; 40353; 11.
DR   ComplexPortal; CPX-420; xtbd-paxt-1 complex.
DR   DIP; DIP-24636N; -.
DR   IntAct; Q9U299; 3.
DR   STRING; 6239.Y48B6A.3; -.
DR   EPD; Q9U299; -.
DR   PaxDb; Q9U299; -.
DR   PeptideAtlas; Q9U299; -.
DR   PRIDE; Q9U299; -.
DR   EnsemblMetazoa; Y48B6A.3.1; Y48B6A.3.1; WBGene00006964.
DR   GeneID; 175071; -.
DR   KEGG; cel:CELE_Y48B6A.3; -.
DR   UCSC; Y48B6A.3; c. elegans.
DR   CTD; 175071; -.
DR   WormBase; Y48B6A.3; CE42702; WBGene00006964; xrn-2.
DR   eggNOG; KOG2044; Eukaryota.
DR   GeneTree; ENSGT00670000098098; -.
DR   HOGENOM; CLU_006038_1_2_1; -.
DR   InParanoid; Q9U299; -.
DR   OMA; CLHYYVH; -.
DR   OrthoDB; 685597at2759; -.
DR   PhylomeDB; Q9U299; -.
DR   Reactome; R-CEL-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   SABIO-RK; Q9U299; -.
DR   PRO; PR:Q9U299; -.
DR   Proteomes; UP000001940; Chromosome II.
DR   Bgee; WBGene00006964; Expressed in multi-cellular organism and 5 other tissues.
DR   GO; GO:0005730; C:nucleolus; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:WormBase.
DR   GO; GO:0008409; F:5'-3' exonuclease activity; ISS:UniProtKB.
DR   GO; GO:0004534; F:5'-3' exoribonuclease activity; IDA:WormBase.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IBA:GO_Central.
DR   GO; GO:0000738; P:DNA catabolic process, exonucleolytic; ISS:UniProtKB.
DR   GO; GO:0006353; P:DNA-templated transcription, termination; IEA:UniProtKB-KW.
DR   GO; GO:0010587; P:miRNA catabolic process; IDA:WormBase.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0060965; P:negative regulation of gene silencing by miRNA; IMP:WormBase.
DR   GO; GO:0000956; P:nuclear-transcribed mRNA catabolic process; IBA:GO_Central.
DR   GO; GO:0040034; P:regulation of development, heterochronic; IGI:WormBase.
DR   GO; GO:0040028; P:regulation of vulval development; IGI:WormBase.
DR   InterPro; IPR027073; 5_3_exoribonuclease.
DR   InterPro; IPR004859; Put_53exo.
DR   InterPro; IPR041412; Xrn1_helical.
DR   InterPro; IPR017151; Xrn2/3/4.
DR   PANTHER; PTHR12341; PTHR12341; 1.
DR   Pfam; PF17846; XRN_M; 2.
DR   Pfam; PF03159; XRN_N; 1.
DR   PIRSF; PIRSF037239; Exonuclease_Xrn2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Developmental protein; Exonuclease; Hydrolase; Metal-binding;
KW   mRNA processing; Nuclease; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation; Transcription termination; Zinc; Zinc-finger.
FT   CHAIN           1..975
FT                   /note="5'-3' exoribonuclease 2 homolog"
FT                   /id="PRO_0000249916"
FT   ZN_FING         262..279
FT                   /note="CCHC-type"
FT   REGION          424..443
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          505..532
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          534..787
FT                   /note="Interaction with paxt-1"
FT                   /evidence="ECO:0000269|PubMed:24462208,
FT                   ECO:0000269|PubMed:26779609"
FT   REGION          804..975
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        506..526
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        804..820
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MUTAGEN         234..236
FT                   /note="DAD->AAA: Abolishes catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:24462208"
FT   HELIX           5..13
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           15..17
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          18..20
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          43..46
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          48..54
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           56..63
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          66..68
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           74..92
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          94..101
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           108..142
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           158..160
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           166..185
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           187..191
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          193..197
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           205..217
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          227..231
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           236..243
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          247..254
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          300..304
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           305..315
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           327..341
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           354..356
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           358..373
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          377..379
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           385..397
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           399..407
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          537..539
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           542..551
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           558..581
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           598..601
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           604..606
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           620..627
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           630..635
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           638..645
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           652..654
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           669..671
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          672..674
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           681..688
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           689..694
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           697..702
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          708..713
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           719..728
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   HELIX           738..741
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          747..749
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          773..775
FT                   /evidence="ECO:0007829|PDB:5FIR"
FT   STRAND          778..784
FT                   /evidence="ECO:0007829|PDB:5FIR"
SQ   SEQUENCE   975 AA;  110128 MW;  219234BA731ABCF6 CRC64;
     MGVPAFFRWL TKKYPATVVN ANEDRQRDQD GNRVPVDCTQ PNPNFQEFDN LYLDMNGIIH
     PCTHPEDRPA PKNEDEMFAL IFEYIDRIYS IVRPRRLLYM AIDGVAPRAK MNQQRSRRFR
     ASKEMAEKEA SIEEQRNRLM AEGIAVPPKK KEEAHFDSNC ITPGTPFMAR LADALRYYIH
     DRVTNDASWA NIEIILSDAN VPGEGEHKIM DYVRKQRGNP AHDPNTVHCL CGADADLIML
     GIATHEANFN IIREEFVPNQ PRACDLCGQY GHELKECRGA ENETDLGDDY CKPEQREKNF
     IFLRIPVLRE YLEKELSMPN LPFKFDVERA LDDWVFLCFF VGNDFLPHLP SLEIREGAID
     RLIKLYKEMV YQMKGYLTKD GIPELDRVEM IMKGLGRVED EIFKRRQQDE ERFQENQRNK
     KARMQMYGGG GRGGRGRGRG RGQQPAFVPT HGILAPMAAP MHHSGESTRQ MASEARQTAM
     KFTNDANETA AANLKALLNV KGEESPADIA SRKRKAEQPL IKPEEEEDEG PKDDIRLYES
     GWKDRYYRAK FDVGSDDIEF RHRVAWAYVE GLCWVLRYYY QGCASWDWYF PYHYAPFASD
     FETVGEFQPD FTRPTKPFNP LEQLMSVFPA ASKQHLPVEW QKLMIQDDSP IIDLYPADFR
     IDLNGKKYAW QGVALLPFVD ETRLLATLQS VYPTLTAEEK QRNTRGPNRI FIGRNHKSFE
     FFQQVAESKS DDLVPLDPTL LNGVSGKIAY DSTATAPGLP FVSPVNHDEC QDLPTNCGIC
     VLYEDPEYPQ DYIFPALRLD GAKEPEKTLK PDDWNDRRDG RYQPQVGFNR NAPRGSLDQS
     GHRQVHHYVR GGGGGGGGYR GNSYDDRRGG GGGGGGYNDR QDFGRNYGGR DGGGPQRYHD
     QQQQRQGGYQ GGGYGGGYGG GGGGGGGGGG GSYHQPYNQD QRRGGRGGGG GPPGYQRPPY
     RGGGGGGYHG NSSWR
//